Conterno Enrique A's Form 4 filing
Kyntra Bio, Inc. (KYNB) · filed Mar 10, 2023
- Accession no.
- 0001209191-23-018064
- Filed
- Mar 10, 2023
- Trade date
- Mar 8-10, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.16M. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001209191-23-020781 (Mar 23, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Conterno Enrique ACIK 0001476151 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2023 | Common Stock | SSaleDisposed | −24,672 | $21.16 | −$522,059.52 | 356,111 | Direct | |
| Mar 8, 2023 | Common Stock | AGrant or awardAcquired | +23,120 | $0.00 | $0 | 379,231 | Direct | |
| Mar 8, 2023 | Common Stock | AGrant or awardAcquired | +37,229 | $0.00 | $0 | 416,460 | Direct | |
| Mar 10, 2023 | Common Stock | SSaleDisposed | −12,103 | $20.20 | −$244,480.6 | 404,357 | Direct | |
| Mar 10, 2023 | Common Stock | SSaleDisposed | −19,486 | $20.20 | −$393,617.2 | 384,868 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.